QLH-14480-74792
2 vaccinations
2 coded responses
21 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 145 / NY
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Pfizer-BioNTech
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-24
- 2021-01-26
- 2021-01-27
- 2021-01-29
- 2021-02-07
-
2021-02-12
Dose 2 — Pfizer-BioNTech
- 2021-02-12
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-15
- 2021-02-16
-
2021-02-17
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-19
- 2021-02-27
- 2021-03-05
- 2021-03-14
- 2021-03-19
- 2021-03-26
-
2021-05-14
Survey response — 3 months, dose 2MedDRA: Blood glucose increased, Hypertension, Menstrual disorder — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Suddenly high blood sugar, higher blood pressure, change in period cycle.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-13
-
2022-02-12
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Hypertriglyceridaemia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Hypertriglyceridemia & 2 miscarriagesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-14 | Unsuccessful | |
| 2022-02-12 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: Suddenly high blood sugar, higher blood pressure, change in period cycle.
Release 11 — 12 months, dose 2
Symptoms: Hypertriglyceridemia & 2 miscarriages
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Blood glucose increased | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Hypertriglyceridaemia | · | · | ✓ |
| SD | Menstrual disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release